Team:HKUST-Hong Kong/notebook.html
From 2011.igem.org
(2 intermediate revisions not shown) | |||
Line 68: | Line 68: | ||
<ul> | <ul> | ||
<li>Genomic DNA of <em>E. coli DH10b</em> extracted</li> | <li>Genomic DNA of <em>E. coli DH10b</em> extracted</li> | ||
- | <li>Waiting for materials to arrive</li> | + | <li>Waiting for materials (bacterial strains, primers) to arrive</li> |
</ul><br> | </ul><br> | ||
- | <p><strong>Week </strong><strong>2</strong><strong> ( | + | <p><strong>Week </strong><strong>2</strong><strong> (13th-17th June)</strong><strong> </strong><br> |
Strain construction</p> | Strain construction</p> | ||
<ul> | <ul> | ||
- | <li>Genomic DNA of <em>E. coli </em> DH10b extracted Genomic DNA of BL21 extracted</li> | + | <li>Genomic DNA of <em>E. coli </em> DH10b extracted. Genomic DNA of BL21 extracted</li> |
- | <li> | + | <li>Cloned out split superfolder GFP construct </li> |
- | <li>Finished design of PCR primers</li> | + | <li>Finished design of PCR primers for nadE gene and λ RED</li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
<ul> | <ul> | ||
<li>Wild type MIC test optimization (kanamycin gradient 0-25 µg/ml, serial dilutions)</li> | <li>Wild type MIC test optimization (kanamycin gradient 0-25 µg/ml, serial dilutions)</li> | ||
- | <li>Constructed standard curve for OD600 verses RR1 CFU concentration </li> | + | <li>Constructed standard curve for OD600 verses RR1 (wild type) CFU concentration </li> |
</ul> | </ul> | ||
<br> | <br> | ||
Line 87: | Line 87: | ||
<ul> | <ul> | ||
<li><i>nadE</i>: PCR out <i>nadE</i> gene from the genome of BL21 </li> | <li><i>nadE</i>: PCR out <i>nadE</i> gene from the genome of BL21 </li> | ||
- | <li>Split superfolder GFP system: The test of the intact superfolder GFP | + | <li>Split superfolder GFP system: The test of the intact (sfGFP 1-10 still ligated together with sfGFP11) superfolder GFP was successful. Confirmation tests and further experiments would be conducted soon.</li> |
- | <li>2010 Slovenia’s method - CFP/YFP: BioBricks | + | <li>2010 Slovenia’s method - CFP/YFP: BioBricks would be transformed into <em>E. coli</em> DH10b. Tests would be conducted soon.</li> |
- | <li>λ RED and oriR101&repA101-ts: pKD46 has arrived and | + | <li>λ RED and oriR101&repA101-ts: pKD46 has arrived and successfully extracted. RFP reporter system was ready. Primers of RepA101ts-OriR101 are ready. </li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
<ul> | <ul> | ||
- | <li>Performed 2nd and 3rd MIC | + | <li>Performed 2nd and 3rd MIC tests for wild type (kanamycin gradient 5-20 µg/ml, 2µg/ml intervals) </li> |
- | <li> | + | <li>Minipreps of BBa_I763007 and BBa_E1010 were successful </li> |
</ul><br> | </ul><br> | ||
<p><strong>Week </strong><strong>4</strong><strong> (2</strong><strong>7</strong><strong>th</strong><strong> June–1st</strong><strong> Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>4</strong><strong> (2</strong><strong>7</strong><strong>th</strong><strong> June–1st</strong><strong> Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | ||
Strain construction</p> | Strain construction</p> | ||
<ul> | <ul> | ||
- | <li>λ RED : protocol design finished | + | <li>λ RED : protocol design finished; pKD46 arrived and digestion tests indicated that the plasmid was correct; PCR RFP with homologous sequence was successful</li> |
<li>2010 Slovenia’s method - CFP/YFP: protocol design finished, successfully finished combined CFP and YFP</li> | <li>2010 Slovenia’s method - CFP/YFP: protocol design finished, successfully finished combined CFP and YFP</li> | ||
- | <li>Split superfolder GFP system: protocol design finished | + | <li>Split superfolder GFP system: protocol design finished; primer arrived</li> |
- | <li>Pir gene and ori-γ: protocol under construction | + | <li>Pir gene and ori-γ: protocol under construction; primer for ori-γ arrived; BW25141 gDNA extraction successful</li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
<ul> | <ul> | ||
- | <li>Ligation of pSB2K3 (from BBa_E1010) with RFP | + | <li>Ligation of pSB2K3 (from BBa_E1010) with RFP reporter device (BBa_I763007) </li> |
<li>Transformation of the RFP/KanR plasmid to <em>E. coli </em>DH10b</li> | <li>Transformation of the RFP/KanR plasmid to <em>E. coli </em>DH10b</li> | ||
</ul><br> | </ul><br> | ||
Line 112: | Line 112: | ||
Strain construction</p> | Strain construction</p> | ||
<ul> | <ul> | ||
- | <li>ori-γ: Primers arrived, PCR was successful. Result: one of four samples | + | <li>ori-γ: Primers arrived, PCR was successful. Result: one of four samples was positive, but of low concentration</li> |
- | <li>pir gene: gDNA of BW25141 extracted</li> | + | <li>pir gene: gDNA of BW25141 successfully extracted</li> |
<li>Split superfolder GFP system: GFP1-10 PCRed, GFP11 PCRed</li> | <li>Split superfolder GFP system: GFP1-10 PCRed, GFP11 PCRed</li> | ||
<li>2010 Slovenia’s method - CFP/YFP: Verified combined fluorescence protein</li> | <li>2010 Slovenia’s method - CFP/YFP: Verified combined fluorescence protein</li> | ||
- | <li>oriR101 & repA101-ts: PCR was successful</li> | + | <li>oriR101 & repA101-ts: Clone- out by PCR was successful</li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
<ul> | <ul> | ||
<li>Successful construction of a RFP-labeled kanamycin-resistant strain</li> | <li>Successful construction of a RFP-labeled kanamycin-resistant strain</li> | ||
- | <li> | + | <li>Information from literature search on mechanisms to raise the MIC for the proposed T4MO mutant slightly help it survive in kanamycin long enough to fulfill its function</li> |
<li>MIC testing for RR-1 </li> | <li>MIC testing for RR-1 </li> | ||
</ul><br> | </ul><br> | ||
Line 127: | Line 127: | ||
Strain construction</p> | Strain construction</p> | ||
<ul> | <ul> | ||
- | <li>λ RED: RFP with homologous sequence | + | <li>λ RED: PCR of RFP with homologous sequence successful</li> |
- | <li>2010 Slovenia’s method - CFP/YFP: digestion and ligation of CFP, YFP with pBluescript promoter finished</li> | + | <li>2010 Slovenia’s method - CFP/YFP: digestion and ligation of CFP, YFP with pBluescript KS+ promoter finished</li> |
<li>Split superfolder GFP system: PCR of spilt superfolder GFP successful</li> | <li>Split superfolder GFP system: PCR of spilt superfolder GFP successful</li> | ||
- | <li>2010 Slovenia’s method - CFP/YFP :Ligation with promoter is successful, but | + | <li>2010 Slovenia’s method - CFP/YFP :Ligation with promoter is successful, but the green fluorescence could not be observed. Considering to redo construction</li> |
- | <li>pToolkit construction: PCR of ori-γ successful | + | <li>pToolkit construction: PCR of ori-γ successful; ligation with pKD46 backbone was done, confirmation still awaiting the results of colony PCR to check the existence of ori-γ; the sequencing PCR of the pir gene was done, now waiting to check the results</li> |
- | <li><i>nadE</i> gene: | + | <li><i>nadE</i> gene: ligation <i>nadE</i> gene with double terminator not successful. Would repeat experiments next week</li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
Line 141: | Line 141: | ||
<ul> | <ul> | ||
<li>Bcr(~1.2kbp): overexpression increases kanamycin MIC ~2-4fold </li> | <li>Bcr(~1.2kbp): overexpression increases kanamycin MIC ~2-4fold </li> | ||
- | <li>NorM (~1.3kbp): | + | <li>NorM (~1.3kbp): overexpression reduces radical oxidative species (e.g. H<sub>2</sub>O<sub>2</sub>) inside the cell</li> |
</ul> | </ul> | ||
</ul><br> | </ul><br> | ||
Line 147: | Line 147: | ||
Strain construction</p> | Strain construction</p> | ||
<ul> | <ul> | ||
- | <li>pir gene: Sequencing product did not meet sequencing requirement – sequencing rejected</li> | + | <li>pir gene: Sequencing product did not meet sequencing requirement (a lot of 'N's) – sequencing rejected. To do: practice how to perform sequencing clean-up properly</li> |
- | <li>Split superfolder GFP system: | + | <li>Split superfolder GFP system: Construct to be ligated had very low recovery from gel purification; another trial would be done asap </li> |
- | <li>2010 Slovenia’s method – CFP/YFP: combination of n-terminal and c-terminal CDS | + | <li>2010 Slovenia’s method – CFP/YFP: combination of n-terminal and c-terminal CDS into same plasmid, driven by plac promoter of pBluescriptKS+ completed. Result: very weak fluorescence observed</li> |
- | <li><em>nadE</em> gene: successful | + | <li><em>nadE</em> gene: successful ligation of nadE gene with terminator; correctness of construct confirmed by restriction digestion tests. Component was putatively finished as biobrick</li> |
<li>oriR101&repA101-ts: basic protocol for site-directed-mutagenesis + fusion PCR tested to be successful. Repeating fusion PCR</li> | <li>oriR101&repA101-ts: basic protocol for site-directed-mutagenesis + fusion PCR tested to be successful. Repeating fusion PCR</li> | ||
<li>λ RED: Previous experiment of gene swapping failed. Trouble-shooting in progress</li> | <li>λ RED: Previous experiment of gene swapping failed. Trouble-shooting in progress</li> | ||
- | <li>pToolkit construction: results from colony PCR of ori-γ from transformed bacteria: successful completion of pToolkit</li> | + | <li>pToolkit construction: results from colony PCR of ori-γ from transformed bacteria: successful completion of pToolkit. Further confirmation by restriction digestion to be done</li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
<ul> | <ul> | ||
- | <li>Mixed culture MIC tests for RFP/KanR and RR1( | + | <li>Mixed culture MIC tests for RFP/KanR and RR1(99:1)</li> |
<li>Multidrug Efflux Pump – Settled on Bcr as the candidate gene </li> | <li>Multidrug Efflux Pump – Settled on Bcr as the candidate gene </li> | ||
<ul> | <ul> | ||
Line 173: | Line 173: | ||
<li>Split superfolder GFP system: Finished ligation of lacI promotor and GFP 11 and verifying. GFP 1-10 PCRing</li> | <li>Split superfolder GFP system: Finished ligation of lacI promotor and GFP 11 and verifying. GFP 1-10 PCRing</li> | ||
<li>2010 Slovenia’s method - CFP/YFP: Finished construction but not verified</li> | <li>2010 Slovenia’s method - CFP/YFP: Finished construction but not verified</li> | ||
- | <li><i>nadE</i> gene: finished</li> | + | <li><i>nadE</i> gene: construction finished, but construct was still harbored in pSB1AK3. Consider relocation to pSB1C3 asap.</li> |
<li>oriR101&repA101-ts: Been ligated to a backbone, verifying</li> | <li>oriR101&repA101-ts: Been ligated to a backbone, verifying</li> | ||
- | <li>λ RED: Waiting for the primers to construct the linear sequence</li> | + | <li>λ RED: Waiting for the primers to construct the linear dsDNA sequence (for swapping)</li> |
+ | <li>pCarrier: Design of Multiple Cloning Site sequence had been completed, waiting for oligos to arrive. | ||
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
<ul> | <ul> | ||
- | <li>Completed the standard curve for | + | <li>Completed the standard curve for OD600 versus RFP/KanR CFU concentration</li> |
<li>Mixed culture MIC tests for RFP/KanR and RR1(1:99)</li> | <li>Mixed culture MIC tests for RFP/KanR and RR1(1:99)</li> | ||
<li>Successfully extracted T4MO from pUC18Not/T4MO, discovering the inclusion of a native constitutive promoter, and ligated to pBlueScript KS+ to create a SpeI site for biobrick assembly. </li> | <li>Successfully extracted T4MO from pUC18Not/T4MO, discovering the inclusion of a native constitutive promoter, and ligated to pBlueScript KS+ to create a SpeI site for biobrick assembly. </li> | ||
Line 188: | Line 189: | ||
<ul> | <ul> | ||
<li>pir gene: Exact location of pir gene in BW25141 is mapped out</li> | <li>pir gene: Exact location of pir gene in BW25141 is mapped out</li> | ||
- | <li>Split superfolder GFP system: Primers | + | <li>Split superfolder GFP system: Primers did not work: a lot of non- specific bindings, expected band size was not clearly present. New primers had been designed; waiting for new primers to come next week</li> |
- | <li>2010 Slovenia’s method - CFP/YFP: CFP ligated with pET. YFP | + | <li>2010 Slovenia’s method - CFP/YFP: CFP ligated with pET. YFP still on progress</li> |
<li>oriR101&repA101-ts: Verifying oriR101&repA101-ts </li> | <li>oriR101&repA101-ts: Verifying oriR101&repA101-ts </li> | ||
<li>λ RED: PCR with the new primers is successful. Modified protocol using KAN-resistance gene to swap out uidA gene</li> | <li>λ RED: PCR with the new primers is successful. Modified protocol using KAN-resistance gene to swap out uidA gene</li> | ||
- | <li>pCarrier: MCS | + | <li>pCarrier: MCS had been hybridized. pSB1K3 is under digestion</li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
Line 206: | Line 207: | ||
<li>λ RED: The swapping seemed to be successful</li> | <li>λ RED: The swapping seemed to be successful</li> | ||
<li>oriR101&repA101-ts: Waiting for new primers</li> | <li>oriR101&repA101-ts: Waiting for new primers</li> | ||
- | <li>pCarrier: MCS and | + | <li>pCarrier: MCS and pSB1AK3 with nadE ligated, but not confirmed </li> |
</ul> | </ul> | ||
<p>Culture Test</p> | <p>Culture Test</p> | ||
Line 267: | Line 268: | ||
</ul> | </ul> | ||
<br> | <br> | ||
- | <p><strong>Week </strong><strong>14 (</strong><strong> | + | <p><strong>Week </strong><strong>14 (</strong><strong>13th-17th Sep)</strong> <br> |
Strain Construction</p> | Strain Construction</p> | ||
<ul> | <ul> |
Latest revision as of 04:00, 29 October 2011
|
Week 1 (4th-10th June)
Week 2 (13th-17th June)
Culture Test
Week 3 (20th-24th June)
Culture Test
Week 4 (27th June–1st July)
Culture Test
Week 5 (8th-12th July)
Culture Test
Week 6 (15th-19th July)
Culture Test
Week 7 (22nd-26th July)
Culture Test
Week 8 (1st-5th Aug)
Culture Test
Week 9 (8th-12th Aug)
Culture Test
Week 10 (15th-19th Aug)
Culture Test
Week 11 (22nd-26th Aug)
Culture Test
Week 12 (29th Aug-1st Sep)
Culture Test
Week 13 (5th-9th Sep)
Culutre Test
Week 14 (13th-17th Sep)
Culture Test
Week 15 (20th-24th Sep)
Week 16 (27th-30th Sep)
|
Our Project Experiments and Results
Strain Construction |
Culture Test |
Modeling Miscellaneous |
iGEM Resources The Team
iGEM Member List |
Contributions Achievements
Medal Requirements |
BioSafety BioBricks |
Human Practice |